These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2125605)

  • 1. Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin.
    Pan HY; DeVault AR; Wang-Iverson D; Ivashkiv E; Swanson BN; Sugerman AA
    J Clin Pharmacol; 1990 Dec; 30(12):1128-35. PubMed ID: 2125605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interaction between propranolol and the HMG-CoA reductase inhibitors pravastatin and lovastatin.
    Pan HY; Triscari J; DeVault AR; Smith SA; Wang-Iverson D; Swanson BN; Willard DA
    Br J Clin Pharmacol; 1991 Jun; 31(6):665-70. PubMed ID: 1907839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of diltiazem with lovastatin and pravastatin.
    Azie NE; Brater DC; Becker PA; Jones DR; Hall SD
    Clin Pharmacol Ther; 1998 Oct; 64(4):369-77. PubMed ID: 9797793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects.
    Singhvi SM; Pan HY; Morrison RA; Willard DA
    Br J Clin Pharmacol; 1990 Feb; 29(2):239-43. PubMed ID: 2106337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin.
    Lilja JJ; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1999 Aug; 66(2):118-27. PubMed ID: 10460065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans.
    Pentikainen PJ; Saraheimo M; Schwartz JI; Amin RD; Schwartz MS; Brunner-Ferber F; Rogers JD
    J Clin Pharmacol; 1992 Feb; 32(2):136-40. PubMed ID: 1613123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo.
    Germershausen JI; Hunt VM; Bostedor RG; Bailey PJ; Karkas JD; Alberts AW
    Biochem Biophys Res Commun; 1989 Feb; 158(3):667-75. PubMed ID: 2493245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Jones P; Kafonek S; Laurora I; Hunninghake D
    Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects.
    Botti RE; Triscari J; Pan HY; Zayat J
    Clin Neuropharmacol; 1991 Jun; 14(3):256-61. PubMed ID: 1906375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase.
    Pan HY
    Eur J Clin Pharmacol; 1991; 40 Suppl 1():S15-8. PubMed ID: 1904355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein has differential effects on the disposition of statin acid and lactone forms in mdr1a/b knockout and wild-type mice.
    Chen C; Lin J; Smolarek T; Tremaine L
    Drug Metab Dispos; 2007 Oct; 35(10):1725-9. PubMed ID: 17640956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
    Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
    Richter WO; Jacob BG; Schwandt P
    Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry.
    Morris MJ; Gilbert JD; Hsieh JY; Matuszewski BK; Ramjit HG; Bayne WF
    Biol Mass Spectrom; 1993 Jan; 22(1):1-8. PubMed ID: 8431499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
    N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.
    Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
    Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of lovastatin extended-release dosage form (Lovastatin XL) in healthy volunteers.
    Lamson M; Phillips G; Shen J; Lukacsko P; Friedhoff L; Niecestro RM
    Biopharm Drug Dispos; 2002 May; 23(4):143-9. PubMed ID: 12015788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
    Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors.
    Bocan TM; Ferguson E; McNally W; Uhlendorf PD; Bak Mueller S; Dehart P; Sliskovic DR; Roth BD; Krause BR; Newton RS
    Biochim Biophys Acta; 1992 Jan; 1123(2):133-44. PubMed ID: 1739744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.